Thank you for Subscribing to Healthcare Business Review Weekly Brief
Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Healthcare Business Review
Thank you for Subscribing to Healthcare Business Review Weekly Brief
By
Healthcare Business Review | Thursday, July 14, 2022
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
The second year of the pandemic has left pharmacies beleaguered but more knowledgeable. Optimizing pharmacists' time and worth is now a top goal. As pharmacists' role in healthcare evolves and pharmacies develop, so will pharmacy automation's function.
FREMONT, CA: After several revolutionary years, pharmacists have assumed roles with a greater emphasis on patient value. For pharmacies to maximize development and stability in a saturated market, this transformation necessitates more accessible and sophisticated automation.
The COVID-19 pandemic has been both a burden and an impetus for pharmacies across the United States, bringing unanticipated obstacles and demanding innovation. And pharmacists responded to supply chain problems, increased patient demands, the vaccination launch, and the expansion of virtual care.
They became specialists in the complex therapies a patient's overburdened practitioner could not convey. They became administrators of vaccines and lifesavers. They advocated for uninsured or underinsured people to access generic or low-cost alternatives.
Check Out This : Auto Business Outlook
This notable change also possesses a singular silver lining. To make this a reality, pharmacists must optimize their operating efficiency. Now is the time to realize the value and potential of these highly licensed individuals.
The COVID-19 pandemic continues to impede and spur pharmacy expansion: Initially, lockdowns and supply chain interruptions appeared to impact the pharmacy industry negatively. The transition from 30-day fills to 90-day fills stretched capacity and resources.
A year and a half ago, many pharmacists viewed their strategy depending on foot traffic and new development sectors, such as specialist therapies.
Although some of these prospects have been severely harmed by social distancing and prescription volume declines, pharmacy income shows hints of stabilization.